131 related articles for article (PubMed ID: 21109952)
1. The proliferation marker Chromatin Assembly Factor-1 is of clinical value in predicting the biological behaviour of salivary gland tumours.
Staibano S; Mascolo M; Rocco A; Lo Muzio L; Ilardi G; Siano M; Pannone G; Vecchione ML; Nugnes L; Califano L; Zamparese R; Bufo P; De Rosa G
Oncol Rep; 2011 Jan; 25(1):13-22. PubMed ID: 21109952
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.
Staibano S; Mascolo M; Mancini FP; Kisslinger A; Salvatore G; Di Benedetto M; Chieffi P; Altieri V; Prezioso D; Ilardi G; De Rosa G; Tramontano D
Histopathology; 2009 Apr; 54(5):580-9. PubMed ID: 19309489
[TBL] [Abstract][Full Text] [Related]
3. Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue?
Staibano S; Mignogna C; Lo Muzio L; Mascolo M; Salvatore G; Di Benedetto M; Califano L; Rubini C; De Rosa G
Histopathology; 2007 Jun; 50(7):911-9. PubMed ID: 17543081
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours.
Polo SE; Theocharis SE; Grandin L; Gambotti L; Antoni G; Savignoni A; Asselain B; Patsouris E; Almouzni G
Histopathology; 2010 Nov; 57(5):716-24. PubMed ID: 21083601
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker.
Mascolo M; Ilardi G; Merolla F; Russo D; Vecchione ML; De Rosa G; Staibano S
Int J Mol Sci; 2012; 13(9):11044-11062. PubMed ID: 23109837
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of p16INK4a and p53 pathway members in benign and malignant myoepithelial tumours of the salivary glands.
Vékony H; Röser K; Löning T; Raaphorst FM; Leemans CR; Van der Waal I; Bloemena E
Histopathology; 2008 Dec; 53(6):658-66. PubMed ID: 19076682
[TBL] [Abstract][Full Text] [Related]
7. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of chromatin assembly factor-1/p60 predicts biological behaviour of laryngeal carcinomas.
Mesolella M; Iorio B; Landi M; Cimmino M; Ilardi G; Iengo M; Mascolo M
Acta Otorhinolaryngol Ital; 2017 Feb; 37(1):17-24. PubMed ID: 28374866
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients.
Mascolo M; Vecchione ML; Ilardi G; Scalvenzi M; Molea G; Di Benedetto M; Nugnes L; Siano M; De Rosa G; Staibano S
BMC Cancer; 2010 Feb; 10():63. PubMed ID: 20178651
[TBL] [Abstract][Full Text] [Related]
11. [Expression of deltaNp63 in salivary gland tumours].
He ZX; Li YN; Liu LK; He HW; Wang D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):126-8. PubMed ID: 16468660
[TBL] [Abstract][Full Text] [Related]
12. High expression level of geminin predicts a poor clinical outcome in salivary gland carcinomas.
Yamazaki M; Fujii S; Murata Y; Hayashi R; Ochiai A
Histopathology; 2010 Jun; 56(7):883-92. PubMed ID: 20497246
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours.
Monteiro LS; Bento MJ; Palmeira C; Lopes C
J Oral Pathol Med; 2009 Jul; 38(6):508-13. PubMed ID: 19317849
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of cell proliferation in major salivary gland carcinomas.
Suzzi MV; Alessi A; Bertarelli C; Cancellieri A; Procaccio L; Dall'olio D; Laudadio P
Acta Otorhinolaryngol Ital; 2005 Jun; 25(3):161-8. PubMed ID: 16450771
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors.
Mori Y; Tsukinoki K; Yasuda M; Miyazawa M; Kaneko A; Watanabe Y
Oral Oncol; 2007 Jul; 43(6):563-9. PubMed ID: 17071132
[TBL] [Abstract][Full Text] [Related]
16. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
Skalova A; Leivo I; Von Boguslawsky K; Saksela E
J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
[TBL] [Abstract][Full Text] [Related]
18. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
[TBL] [Abstract][Full Text] [Related]
19. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
20. The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis.
Schwarz S; Zenk J; Müller M; Ettl T; Wünsch PH; Hartmann A; Agaimy A
Histopathology; 2012 Sep; 61(3):395-408. PubMed ID: 22551398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
